TCM.CO(TCM.CO)
TCM.CO
No analyst ratings available
No analyst price targets available for TCM.CO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.48B | $1.57B | $1.65B | $1.80B | $1.89B |
| Low | $1.48B | $1.56B | $1.64B | $1.79B | $1.88B |
| High | $1.49B | $1.57B | $1.67B | $1.81B | $1.90B |
| EBITDA Avg | $153M | $162M | $171M | $186M | $195M |
| Low | $152M | $161M | $169M | $185M | $194M |
| High | $154M | $162M | $172M | $186M | $196M |
| EBIT Avg | $118M | $125M | $132M | $143M | $150M |
| Low | $117M | $124M | $130M | $143M | $150M |
| High | $119M | $125M | $133M | $144M | $151M |
| Net Income Avg | $81M | $107M | $124M | $140M | $159M |
| Low | $79M | $101M | $117M | $140M | $158M |
| High | $88M | $112M | $128M | $141M | $160M |
| EPS Avg | $8.05 | $10.24 | $11.78 | $13.50 | $15.30 |
| Low | $7.61 | $9.72 | $11.21 | $13.44 | $15.23 |
| High | $8.50 | $10.75 | $12.35 | $13.56 | $15.37 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $339M | $385M |
| Low | $337M | $382M |
| High | $341M | $387M |
| EBITDA Avg | $35M | $40M |
| Low | $35M | $39M |
| High | $35M | $40M |
| EBIT Avg | $27M | $31M |
| Low | $27M | $30M |
| High | $27M | $31M |
| Net Income Avg | $9M | $13M |
| Low | $9M | $13M |
| High | $9M | $13M |
| EPS Avg | $0.85 | $1.29 |
| Low | $0.84 | $1.28 |
| High | $0.86 | $1.30 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |